Expertise Meets Innovation
We create solutions for the future of telemedicine
Who We Are
SEMDATEX is a SaaS company specializing in the development of software for Remote Patient Management. Our journey began in 2017, when two pioneers with extensive experience in telemedicine founded the company in Berlin. At Semdatex, patient well-being and innovation are at the core of everything we do.
Our vision was clear from the start: we aim to revolutionize patient care through innovative technologies and digital solutions. By 2023, SEMDATEX achieved market leadership in Germany with a 70% market share through inCareNet HF.
Our goal is to actively support our clients in navigating the upcoming challenges in healthcare through digital health and telemedicine applications, patient communication, and E-health networking. We believe in the power of centralized, hub-based remote monitoring and early diagnosis.
With more than 140 Telemedicine Centers (TMC) relying on our solutions, we are setting new standards in remote monitoring and care for heart failure patients. As our network continues to grow, we are constantly advancing our technologies to meet the evolving demands of the healthcare industry.
Our mission is to improve the quality of life for patients while equipping physicians and medical professionals with the tools they need for efficient and precise care. Through close collaboration with leading medical institutions and ongoing research and development, we strive to transform healthcare in Germany and beyond.
Timeline:
2017: Founded in Berlin by two pioneers in the field of Remote Patient Management (RPM).
2019: Development of inPACE, our first electronic follow-up workflow, setting a new standard in patient care.
2020: Participation in the TIMELY Project Consortium (EU 2020 Project).
2021: Development of inCareNet HF, a groundbreaking solution for heart failure management, and relocation to Adlershof, one of Berlin's leading science and technology parks.
2024: SEMDATEX becomes a consortium partner in the FACE project, funded by the Federal Ministry of Education and Research (BMBF).
